You are here

  • Home
  • Archive
  • Volume 69, Issue Suppl 1
  • P58 Economic evaluation of the GORE® VIATORR® stent in patients with complications of severe cirrhosis – ascites and bleeding: a UK cost-utility analysis

Article info

Article menu

Download PDFPDF

Abstracts
P58 Economic evaluation of the GORE® VIATORR® stent in patients with complications of severe cirrhosis – ascites and bleeding: a UK cost-utility analysis
Free

Authors

Citation

Tripathi D, O’Neill F, Patch D, et al
P58 Economic evaluation of the GORE® VIATORR® stent in patients with complications of severe cirrhosis – ascites and bleeding: a UK cost-utility analysis
Gut 2020;69:A35.

Publication history

  • First published September 28, 2020.
Online issue publication 
September 28, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.